Dr. Alden M. Doyle, MD

Dr. Doyle practices at UVA University Medical Center in Charlottesville, Virginia.

Dr. Doyle's NPI, 1881629921, was assigned on July 11, 2006. Dr. Doyle graduated from Tulane University School of Medicine in 1994. Dr. Doyle holds Virginia license 0101261362.

Dr. Doyle's primary practice is UVA University Medical Center, at 1215 Lee St, Charlottesville, VA 22908 in Charlottesville City. The practice phone is (434) 760-3439.

Dr. Doyle's primary practice is UVA University Medical Center in Charlottesville, Virginia. Dr. Doyle is also affiliated with University Medical Center. The medical group on file is UVA Physicians Group. Dmand AI also links Dr. Doyle to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Doyle practices, 6 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Doyle's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dmand AI has Dr. Doyle's licenses on file in 2 states: Virginia and Pennsylvania.

CMS data shows 651 Medicare services from Dr. Doyle across 4 procedure codes in 2024, for 188 Medicare patients. Medicare paid $47,866 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 188 Medicare patients who saw Dr. Doyle in 2024. The largest group is under 65, with 84 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 19% are also on Medicaid. Their average risk score is 5.36, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Doyle's median patient age at 58, with 43% women.

In 2024, Dr. Doyle wrote 1,397 Medicare Part D claims for 200 patients. 87% of them were for generic drugs. CMS names the drug for 1,206 of them, across 32 drugs with 11 or more claims each, at $164,330 in total drug cost. In 2023, CMS named 1,443 claims across 38 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Doyle for performance year 2024, reported as part of a group. Dr. Doyle accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Doyle as offering telehealth.

Dmand AI links 43 papers to Dr. Doyle, published from 2011 to 2025. 2019 was the busiest year, with 4. The most frequent topics are Kidney Transplantation, Immunosuppressive Agents and Organ Transplantation. Dr. Doyle has published most often in Am J Transplant. Dr. Doyle's most frequent co-authors are Dong Heun Lee, MD, Karthik M. Ranganna, MD and Suzanne M. Boyle, MD.

CMS Open Payments shows 4 general payments to Dr. Doyle from 2 drug and device companies from 2019 to 2025. Education make up the largest share, 100% of the total. Alexion Pharmaceuticals, Inc. paid the most, $185.

Dr. Doyle graduated from Tulane University School of Medicine in 1994.